Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Postural Orthostatic Tachycardia Syndrome 1 Multiple Myeloma 1 Mastocytosis 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Bronchopulmonary Disease 1

Interventions

Cisplatin 6 pembrolizumab 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Fulvestrant 3 palbociclib 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiation Dose Hypofractionation 2 Radiation 2 Platinum 2 Paclitaxel 2 Fluorouracil 2 Fluorodeoxyglucose F18 2 Drug Therapy 2 Congresses as Topic 2 Carboplatin 2 Brachytherapy 2 Biopsy 2 Bevacizumab 2 Axitinib 2 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 2 1,2-diaminocyclohexaneplatinum II citrate 2 zimberelimab 1 ulixertinib 1 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 trametinib 1 tisotumab vedotin 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Mass Screening × 30 days × Clear all

NCT06042543 2026-06-01

EASTER

International Agency for Research on Cancer

Phase NA Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡